Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines

被引:76
作者
Zanin-Zhorov, A
Bruck, R
Tal, G
Oren, S
Aeed, H
Hershkoviz, R
Cohen, IR [1 ]
Lider, O
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[2] E Wolfson Med Ctr, Dept Gastroenterol, Holon, Israel
[3] Dept Internal Med D, Zerifin, Israel
[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.4049/jimmunol.174.6.3227
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Extracellular heat shock protein 60 (HSP60) has been considered a proinflammatory danger signal. Yet, HSP60 can also down regulate experimental immune arthritis and diabetes models by specific inhibition of Th1-like responses. We now report that HSP60 in vitro differentially modulates the expression of Th1/Th2 transcription factors in human T cells: HSP60 down-regulates T-bet, NF-kappaB, and NFATp and up-regulates GATA-3, leading to decreased secretion of TNF-alpha and IFN-gamma and enhanced secretion of IL-10. These effects depended on TLR2 signaling and could not be attributed to LPS or to other contaminants. In BALB/c mice, HSP60 in vivo inhibited the clinical, histological, and serological manifestations of Con A-induced hepatitis associated with up-regulated T cell expression of suppressor of cytokine signaling 3 and GATA-3 and down-regulated T-bet expression. These results provide a molecular explanation for the effects of HSP60 treatment on T cell inflammation via innate regulation of the inflammatory response.
引用
收藏
页码:3227 / 3236
页数:10
相关论文
共 44 条
[1]   Cutting edge: Different toll-like receptor agonists instruct dendritic cells to induce distinct th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-fos [J].
Agrawal, S ;
Agrawal, A ;
Doughty, B ;
Gerwitz, A ;
Blenis, J ;
Van Dyke, T ;
Pulendran, B .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :4984-4989
[2]   Toll-like receptor signaling pathways [J].
Barton, GM ;
Medzhitov, R .
SCIENCE, 2003, 300 (5625) :1524-1525
[3]   Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces th2-type antibodies [J].
Bockova, J ;
Elias, D ;
Cohen, IR .
JOURNAL OF AUTOIMMUNITY, 1997, 10 (04) :323-329
[4]   Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells [J].
Coccia, EM ;
Severa, M ;
Giacomini, E ;
Monneron, D ;
Remoli, ME ;
Julkunen, I ;
Cella, M ;
Lande, R ;
Uzé, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) :796-805
[5]   A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells [J].
Dillon, S ;
Agrawal, A ;
Van Dyke, T ;
Landreth, G ;
McCauley, L ;
Koh, A ;
Maliszewski, C ;
Akira, S ;
Pulendran, B .
JOURNAL OF IMMUNOLOGY, 2004, 172 (08) :4733-4743
[6]   Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens [J].
Elias, D ;
Meilin, A ;
Ablamunits, V ;
Birk, OS ;
Carmi, P ;
KonenWaisman, S ;
Cohen, IR .
DIABETES, 1997, 46 (05) :758-764
[7]   Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor α from murine macrophages [J].
Gao, BC ;
Tsan, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (25) :22523-22529
[8]   NF-κB and rel proteins:: Evolutionarily conserved mediators of immune responses [J].
Ghosh, S ;
May, MJ ;
Kopp, EB .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :225-260
[9]  
Glimcher LH, 2000, GENE DEV, V14, P1693
[10]  
HOMUNG V, 2002, J IMMUNOL, V168, P4531